Skip to main content
News BMZ II

News categories: Honors & Funding

ImmunoSensation members among "highly cited researchers"

Five scientists from ImmunoSensation2 are among the world's most cited researchers, annualy published by the information service provider Clarivate Analytics. Once more, Prof. Joachim Schultze (DZNE), Prof. Andreas Schlitzer (LIMES) and Prof. Eicke Latz (DRFZ), Prof. Jonathan Schmid-Burgk (UKB) and Thomas Bieber (UKB) are part of the impressive list.

According to the compilers of the ranking, the people on this list of ‘Highly Cited Researchers’ are among the world's most influential one per cent in their field. The list contains around 6,600 researchers from 59 countries. From Germany, 332 researchers have made it onto the list - including ten from the University of Bonn


The benchmark is the frequency with which scientific publications have been cited by other researchers in the last ten years (period from 2013 to 2023). For the analysis, the creators of the list divided the publications into 20 subject areas and introduced the ‘Cross-Field’ section, which lists researchers who have published in several subject areas.

The ranking is published annually by the ‘Web of Science Group’ and can be found here.

 

Related news

Prof. Dr. Kaan Boztug

News categories: Honors & Funding

Kaan Boztug awarded Novartis Prize

Prof. Dr. Kaan Boztug from the University Hospital Bonn (UKB) receives the Novartis Prize for Therapy-Relevant Immunological Research 2025. The expert in rare diseases of the immune system and blood formation conducted most of the research work that has now been honored in Vienna. His work was supported by an ERC Starting Grant (ImmunoCore, 2012-2018) and an ERC Consolidator Grant (iDysChart, 2019-2025), among others. The science prize, worth 10,000 € is divided into two parts this time and also goes to Prof. Dr. Evelyn Ullrich.
View entry
Niklas Klümper

News categories: Honors & Funding

Niklas Klümper Receives Johann-Georg-Zimmermann Prize

PD Dr. Niklas Klümper was honored with the prestigious Johann-Georg-Zimmermann Research Prize. The €10,000 award is presented annually to young cancer researchers for their current scientific contributions.
View entry
Speakers of ImmunoSensation

News categories: Honors & Funding

ImmunoSensation goes into the next round

The Bonn Cluster of Excellence ImmunoSensation will be funded for further seven years as part of the Excellence Strategy of the German federal and state governments. The aim of the new funding period, which begins on January 1, 2026, is to research immune diversity: the structural, functional and dynamic diversity of the immune system. Involved are the University of Bonn, the University Hospital Bonn (UKB) and the German Center for Neurodegenerative Diseases (DZNE). The funding amounts to around 50 million euros.
View entry

Back to the news overview